These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10423615)

  • 1. Pharmacokinetics of ipriflavone and metabolites after oral administration of a corn-oil suspension relative to the Osteofix tablet.
    Rohatagi S; Barrett JS; Sawyers W; Yu K; Morales RJ
    Am J Ther; 1997; 4(7-8):229-38. PubMed ID: 10423615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated pharmacokinetic and metabolic modeling of ipriflavone and metabolites after oral administration.
    Rohatagi S; Barrett JS
    Am J Ther; 1997; 4(5-6):189-98. PubMed ID: 10423610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes.
    Acerbi D; Poli G; Ventura P
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):172-7. PubMed ID: 9725477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.
    Krishna G; Ma L; Martinho M; O'Mara E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4196-201. PubMed ID: 22615291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
    Chen L; Krekels EHJ; Heijnen AR; Knibbe CAJ; Brüggemann RJ
    Drugs; 2023 Jan; 83(1):75-86. PubMed ID: 36607589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
    Rondelli I; Acerbi D; Ventura P
    Int J Clin Pharmacol Res; 1991; 11(4):183-92. PubMed ID: 1813437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants.
    Schueller O; Regev G; Singh N; Willson A; Beville M; Kanji N; Lohmer L; Patel J
    Clin Pharmacol Drug Dev; 2024 May; 13(5):491-498. PubMed ID: 38345529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects.
    Flesch G; Tudor D; Denouel J; Bonner J; Camisasca R
    Int J Clin Pharmacol Ther; 2003 Jul; 41(7):299-308. PubMed ID: 12875346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
    Chung HJ; Kang HE; Bae EJ; Lee I; Kim SG; Lee MG
    J Pharm Sci; 2008 Nov; 97(11):5024-36. PubMed ID: 18314883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of bioequivalence of a generic mefloquine tablet with the standard product.
    Weidekamm E; Rüsing G; Caplain H; Sörgel F; Crevoisier C
    Eur J Clin Pharmacol; 1998 Oct; 54(8):615-9. PubMed ID: 9860148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans.
    Bates TR; Sequeria JA
    J Pharm Sci; 1975 May; 64(5):793-7. PubMed ID: 1151647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.